Emerging Predictive Biomarkers in Breast Cancer
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: 31 October 2025 | Viewed by 48
Special Issue Editors
Interests: breast cancer; HER2-positive; HER2-negative; ER+; HER2-low; liquid biopsy; immunotherapy; targeted therapy; molecular biology
Special Issue Information
Dear Colleagues,
The treatment landscape of breast cancer has profoundly changed over the last few years with the approval of several new therapeutic options for both early-stage and advanced/metastatic disease. Much progress has been made in discerning the molecular pathology of breast cancer, leading to the identification of different molecular subtypes with distinct clinical–pathological characteristics and therapeutic vulnerabilities. Recently, new novel classes of therapeutic agents have emerged in clinical practice, including immune checkpoint inhibitors and antibody drug conjugates, but there is a lack of reliable predictive biomarkers for these agents, and in some cases, they are still used with a one-size-fits-all approach. Furthermore, the use of circulating biomarkers, namely liquid biopsy, and novel PET tracers in indications is rapidly growing, offering the possibility of further innovating the patient selection process for novel breast cancer therapies.
The aim of this Special Issue is to expand the current knowledge on the molecular, genetic and therapeutic landscape of breast cancer, with a particular focus on novel prognostic and predictive biomarkers that could have an impact on clinical practice. Experimental studies in in vitro and in vivo models, review articles, and clinical studies will be considered.
Dr. Giuseppina Rosaria Rita Ricciardi
Guest Editor
Dr. Maria Vita Sanò
Guest Editor Assistant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- breast cancer
- HER2-positive
- TNBC
- ER+
- HER2-negative
- HER2-low
- PD-L1
- 18F-FES PET
- hormonotherapy
- immunotherapy
- immune checkpoint inhibitors
- liquid biopsy
- circulating tumor cells
- ctDNA
- antibody drug conjugates
- PARP inhibitors
- CDK4/6 inhibitors
- predictive biomarkers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
